175140-70-2

Basic information

• Product Name: 4-Pyrimidinamine, 6-chloro-2-methyl-5-nitro-N-(2,4,6-trimethylphenyl)-
• CAS NO: 175140-70-2
• Molecular Formula: C14H15ClN4O2
• Molecular Weight: 306.752
• Mol File: 175140-70-2.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 4-Pyrimidinamine, 6-chloro-2-methyl-5-nitro-N-(2,4,6-trimethylphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Pyrimidinamine, 6-chloro-2-methyl-5-nitro-N-(2,4,6-trimethylphenyl)-(175140-70-2)
• EPA Substance Registry System: 4-Pyrimidinamine, 6-chloro-2-methyl-5-nitro-N-(2,4,6-trimethylphenyl)-(175140-70-2)

Safety Data

• Hazardous Substances Data: 175140-70-2(Hazardous Substances Data)

Upstream product

• 13162-43-1 4,6-dichloro-2-methyl-5-nitropyrimidine 
• 88-05-1 2,4,6-trimethylaniline 
• 53925-27-2 2-methyl-4,6-dihydroxy-5-nitropyrimidine 
• 82779-50-8 4,6-dichloro-2-methyl-5-nitropyrimidine 
• 1194-22-5 2-methyl-4,6-dihydroxypyrimidine 
• 197802-86-1 2-methyl-5-nitro-6-(2,4,6-trimethyl-phenylamino)-3H-pyrimidin-4-one 

Downstream Products

• 1026880-85-2 2-methyl-5-nitro-N-(1-propyl-butyl)-N'-(2,4,6-trimethyl-phenyl)-pyrimidine-4,6-diamine 
• 1026336-73-1 N-(1-ethyl-pentyl)-2-methyl-5-nitro-N'-(2,4,6-trimethyl-phenyl)-pyrimidine-4,6-diamine 
• 175139-13-6 4-N-(2,4,6-trimethylphenyl)-6-(N-n-butylethylamino)-2-methyl-5-nitropyrimidin-4-amine 
• 1027590-10-8 N-ethyl-N-(2-methoxy-ethyl)-2-methyl-5-nitro-N'-(2,4,6-trimethyl-phenyl)-pyrimidine-4,6-diamine 
• 1026923-44-3 N,N-bis-(2-methoxy-ethyl)-2-methyl-5-nitro-N'-(2,4,6-trimethyl-phenyl)-pyrimidine-4,6-diamine 
• 1026652-10-7 N-(1-methoxymethyl-propyl)-2-methyl-5-nitro-N'-(2,4,6-trimethyl-phenyl)-pyrimidine-4,6-diamine 
• 175140-14-4 N-(1-Ethyl-propyl)-2-methyl-N-(2,4,6-trimethyl-phenyl)-pyrimidine-4,5,6-triamine 
• 1026805-51-5 2-methyl-N-(1-methyl-butyl)-N''-(2,4,6-trimethyl-phenyl)-pyrimidine-4,5,6-triamine 

Relevant articles and documents

Corticotropin releasing factor antagonists

Corticotropin-releasing factor (CRF) antagonists having the formulae wherein the dashed lines, A, B, Y, Z, G, R3, R4, R5, R6, R16 and R17 are as defined in the application, and processes fo

Purin-8-ones as corticotropin-releasing hormone (CRH-R1) receptor antagonists

A series of purin-8-ones was prepared and discovered to have excellent binding affinity to the CRH-R1 receptor. Structure-activity studies focused on amine side-chain optimization, urea substitution and pyridyl isostere incorporation. Thus, the highly potent purin-8-ones show promise as a new class of potential anxiolytics and/or antidepressants.